Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

March 24, 2019

Study Completion Date

December 20, 2019

Conditions
Diabetes Mellitus, Type 2NSTEMI - Non-ST Segment Elevation MICoronary Angioplasty
Interventions
DRUG

Clopidogrel

COPIGREL® - clopidogrel dosed at 75 mg per tablet

Trial Locations (1)

Unknown

HMPIT, Ben Arous

Sponsors
All Listed Sponsors
lead

Laboratoires Teriak

INDUSTRY